Phathom Pharmaceuticals (PHAT) Return on Assets (2022 - 2025)
Historic Return on Assets for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 1.12%.
- Phathom Pharmaceuticals' Return on Assets fell 1600.0% to 1.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.12%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.84% for FY2024, which is 1500.0% down from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Return on Assets is 1.12%, which was down 1600.0% from 1.21% recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Return on Assets registered a high of 0.62% during Q4 2023, and its lowest value of 1.26% during Q1 2023.
- Its 4-year average for Return on Assets is 0.94%, with a median of 0.93% in 2023.
- In the last 5 years, Phathom Pharmaceuticals' Return on Assets skyrocketed by 6200bps in 2024 and then crashed by -3900bps in 2025.
- Phathom Pharmaceuticals' Return on Assets (Quarter) stood at 1.08% in 2022, then skyrocketed by 43bps to 0.62% in 2023, then plummeted by -41bps to 0.87% in 2024, then decreased by -28bps to 1.12% in 2025.
- Its Return on Assets was 1.12% in Q3 2025, compared to 1.21% in Q2 2025 and 1.03% in Q1 2025.